Joshua K. Sabari, MD, of NYU Langone Health discusses promising results for zongertinib in HER2-mutant NSCLC; the tyrosine ...

Low back pain remains the leading cause of YLDs globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide. While age-standardised rates have decreased ...

ABU DHABI, 17th June, 2025 (WAM) -- The Department of Health - Abu Dhabi (DoH) signed a Memorandum of Understanding with Boehringer Ingelheim, one of the world's leading research-driven ...

The LCRF|Boehringer Ingelheim Early Career Investigator's Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer is expected to total $750,000 for up to three, two-year ...

NEW YORK – The Lung Cancer Research Foundation and Boehringer Ingelheim have jointly created two funding opportunities, through which researchers exploring new treatments for HER2-mutated lung cancer ...

The LCRF|Boehringer Ingelheim Team Science Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer award, is a $1.5 million, three-year award to a team of researchers whose ...

In response to hints of “biosignatures” found on a world called K2-18b, new research suggests there’s a lot of uncertainty surrounding the exoplanet. CNN’s Ashley Strickland reports on the ...

In a new discovery, chronic pain has been shown to be physiologically different from acute pain and now scientists have the roadmap for how to target it. Topics. Conditions. Week's top; ...

On their own, these early signs of a heart attack could be easily dismissed, but experts urge you to acknowledge when they arise suddenly and respond accordingly. “Don’t wait for the classic ...

Transpire Bio has licensed an inhaled PDE4 inhibitor from China’s Intragrand Pharma as a potential treatment for idiopathic pulmonary fibrosis.

Participants had regular medical exams and completed health questionnaires. Researchers reviewed results to determine if they had early signs of Parkinson’s disease, including rapid eye movement sleep ...